University of AntwerpContact : Delputte Peter, Professoremail : peter.delputte@uantwerpen.be
Keywords : novel technology, adjuvant, immunology, vaccine development, mode of action, toll-like receptor, route of administration, clinical research, vaccine safety
Aims of “Vaccine administration routes & adjuvants”
This course will be designed in close collaboration with our industrial partners
- Adjuvant definition Adjuvant families
- Role of adjuvants: Why do we need adjuvants?
- Matching the right one: Antigens may need help - why and when?
- General adjuvant mode of action (MoA): immunological interpretation, relationship between innate and adaptive immunity
- Pre-clinical and clinical experience using novel adjuvants in vaccine formulations, impact on immune response
- Clinical tolerability, safety considerations and current safety profile of adjuvanted vaccines
- Learning & challenges in developing, manufacturing and licensing AS-containing vaccines
- Considerations for use of adjuvanted vaccines in special populations
- Novel technologies, including routes of administrations
- Advances in Immunology and Vaccine Discovery: Considerations for future applications-
Tutorials: will involve the reading relevant articles covering various topics of this course. Series of didactic presentations and practical exercises through group work.
Speakers:
Marcelle Van Mechelen, Alberta Di Pasquale, Gérald Voss, Arnaud Didierlaurent, Fernanda Tavares Da Silva, Ozzie Berger, Jean Gilliard
Learning outcomes:
Strengthen capacity in vaccinology with comprehensive overview of the field, discuss recent scientific advances contributing to the progress of vaccine development, specifically related to adjuvants, novel technologies and routes of administrations.
Updated on April 9, 2019
